1.
Ċobejko K, Mitosek-Szewczyk K, Kurzepa J, Berbecki J, Stelmasiak Z. Bilirubin and uric acid serum levels in patients with relapsing-remitting multiple sclerosis after the first phase of cladribine treatment. Curr. Issues Pharm. Med. Sci. 2025;23(1):137-142. Accessed August 17, 2025. https://czasopisma.umlub.pl/curipms/article/view/2855